{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:56:38Z","timestamp":1781780198881,"version":"3.54.5"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:p>\n            Whether changes over time of urinary albumin excretion have prognostic value is a matter of discussion. The objective was to assess the prognostic value of changes in urinary albumin excretion over time in cardiovascular risk during antihypertensive treatment. Follow-up study of 2835 hypertensives in the absence of previous cardiovascular disease (mean age 55 years, 47% men, BP 138\/80 mm Hg, 19.1% diabetics, and calibrated systemic coronary risk estimation 5 or &gt;10.6%). Usual-care of antihypertensive treatment was implemented to maintain blood pressure &lt;140\/90 mm Hg. Urinary albumin excretion was assessed yearly, and the values were expressed as the creatinine ratio. Incidence of cardiovascular events, fatal and nonfatal, was recorded during the follow-up. During a median follow-up of 4.7 years (17 028 patients-year), 294 fatal and first nonfatal cardiovascular events were recorded (1.73 CVD per 100 patients\/year). Independently of blood pressure, estimated glomerular filtration rate, level of cardiovascular risk, and antihypertensive treatment, microalbuminuria at baseline and at any time during the follow-up resulted in higher risk for events, hazard ratio (HR) 1.35 (95% confidence interval [CI], 1.08\u20131.79) and HR 1.49 (95% CI, 1.14\u20131.94), respectively. Likewise, development of microalbuminuria (HR 1.60; 95% CI, 1.04\u20132.46) or persistence from the beginning (1.53; 95% CI, 1.13\u20132.06) had a significantly higher rate of events than if remained normoalbuminuric (HR 1) or regress to normoalbuminuria (HR 1.37; 95% CI, 0.92\u20132.06) with an 18%, 18%, 8%, and 11% events, respectively,\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001. The study supports the value of urinary albumin excretion assessment as a prognostic factor for cardiovascular risk, but also opens the way to consider it as an intermediate objective in hypertension.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.114.04273","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T07:35:28Z","timestamp":1411457728000},"page":"1228-1234","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":51,"title":["Prognostic Value of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension"],"prefix":"10.1161","volume":"64","author":[{"given":"Jose Maria","family":"Pascual","sequence":"first","affiliation":[{"name":"From the Hypertension Clinic, Sagunto Hospital, Valencia, Spain (J.M.P., E.R., J.A.C., M.G.-E., C.G.); CIBER Fisiopatolog\u00eda Obesidad y Nutrici\u00f3n (CB06\/03), Instituto de Salud Carlos III, Madrid, Spain (J.M.P., J.R.); and Hypertension Clinic, Hospital Clinico, Research Institute INCLIVA, University of Valencia, Spain (J.R.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Rodilla","sequence":"additional","affiliation":[{"name":"From the Hypertension Clinic, Sagunto Hospital, Valencia, Spain (J.M.P., E.R., J.A.C., M.G.-E., C.G.); CIBER Fisiopatolog\u00eda Obesidad y Nutrici\u00f3n (CB06\/03), Instituto de Salud Carlos III, Madrid, Spain (J.M.P., J.R.); and Hypertension Clinic, Hospital Clinico, Research Institute INCLIVA, University of Valencia, Spain (J.R.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Costa","sequence":"additional","affiliation":[{"name":"From the Hypertension Clinic, Sagunto Hospital, Valencia, Spain (J.M.P., E.R., J.A.C., M.G.-E., C.G.); CIBER Fisiopatolog\u00eda Obesidad y Nutrici\u00f3n (CB06\/03), Instituto de Salud Carlos III, Madrid, Spain (J.M.P., J.R.); and Hypertension Clinic, Hospital Clinico, Research Institute INCLIVA, University of Valencia, Spain (J.R.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Garcia-Escrich","sequence":"additional","affiliation":[{"name":"From the Hypertension Clinic, Sagunto Hospital, Valencia, Spain (J.M.P., E.R., J.A.C., M.G.-E., C.G.); CIBER Fisiopatolog\u00eda Obesidad y Nutrici\u00f3n (CB06\/03), Instituto de Salud Carlos III, Madrid, Spain (J.M.P., J.R.); and Hypertension Clinic, Hospital Clinico, Research Institute INCLIVA, University of Valencia, Spain (J.R.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"From the Hypertension Clinic, Sagunto Hospital, Valencia, Spain (J.M.P., E.R., J.A.C., M.G.-E., C.G.); CIBER Fisiopatolog\u00eda Obesidad y Nutrici\u00f3n (CB06\/03), Instituto de Salud Carlos III, Madrid, Spain (J.M.P., J.R.); and Hypertension Clinic, Hospital Clinico, Research Institute INCLIVA, University of Valencia, Spain (J.R.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Redon","sequence":"additional","affiliation":[{"name":"From the Hypertension Clinic, Sagunto Hospital, Valencia, Spain (J.M.P., E.R., J.A.C., M.G.-E., C.G.); CIBER Fisiopatolog\u00eda Obesidad y Nutrici\u00f3n (CB06\/03), Instituto de Salud Carlos III, Madrid, Spain (J.M.P., J.R.); and Hypertension Clinic, Hospital Clinico, Research Institute INCLIVA, University of Valencia, Spain (J.R.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198402093100605"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92657-8"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6720.297"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.10.5.727"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816090-00014"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.8.1992"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.3.617"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc2501.091353"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.4.421"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000103667.27493.32"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-006-0015-x"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.03.06.dc05-1724"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61303-8"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008070667"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0959"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010091001"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62100-0"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007994"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.000810"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437741.48606.98"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000003"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.2.712"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_3_3_27_2","unstructured":"European Society of Cardiology. Systematic COronary Risk Evaluation. http:\/\/www.escardio.org\/communities\/EACPR\/toolbox\/health-professionals\/Pages\/SCORE-Risk-Charts.aspx. Accessed January 15 2013."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000167151.52825.11"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00285287"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg314"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000249707.36393.02"},{"key":"e_1_3_3_32_2","first-page":"577","article-title":"Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension.","volume":"5","author":"Thoenes M","year":"2009","unstructured":"Thoenes M, Reil JC, Khan BV, Bramlage P, Volpe M, Kirch W, B\u00f6hm M. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag. 2009;5:577\u2013585.","journal-title":"Vasc Health Risk Manag"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000093461.36097.D5"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328333afb3"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.171"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.5.685"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp546"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283525715"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328356c579"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328361461e"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-012-0270-y"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.114.04273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:49:14Z","timestamp":1715593754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.114.04273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.114.04273"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.114.04273","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"2014-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-09-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}